rs11160707
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_145725.3(TRAF3):c.*2589G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.019 in 152,688 control chromosomes in the GnomAD database, including 156 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.019 ( 156 hom., cov: 34)
Exomes 𝑓: 0.0034 ( 0 hom. )
Consequence
TRAF3
NM_145725.3 3_prime_UTR
NM_145725.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.120
Publications
7 publications found
Genes affected
TRAF3 (HGNC:12033): (TNF receptor associated factor 3) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from, members of the TNF receptor (TNFR) superfamily. This protein participates in the signal transduction of CD40, a TNFR family member important for the activation of the immune response. This protein is found to be a critical component of the lymphotoxin-beta receptor (LTbetaR) signaling complex, which induces NF-kappaB activation and cell death initiated by LTbeta ligation. Epstein-Barr virus encoded latent infection membrane protein-1 (LMP1) can interact with this and several other members of the TRAF family, which may be essential for the oncogenic effects of LMP1. The protein also plays a role in the regulation of antiviral response. Mutations in this are associated with Encephalopathy, acute, infection-induced, herpes-specific 5. [provided by RefSeq, Jul 2020]
TRAF3 Gene-Disease associations (from GenCC):
- TRAF3 haploinsufficiencyInheritance: AD Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRAF3 | NM_145725.3 | c.*2589G>A | 3_prime_UTR_variant | Exon 12 of 12 | ENST00000392745.8 | NP_663777.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TRAF3 | ENST00000392745.8 | c.*2589G>A | 3_prime_UTR_variant | Exon 12 of 12 | 1 | NM_145725.3 | ENSP00000376500.3 |
Frequencies
GnomAD3 genomes AF: 0.0189 AC: 2878AN: 152274Hom.: 154 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
2878
AN:
152274
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00338 AC: 1AN: 296Hom.: 0 Cov.: 0 AF XY: 0.00450 AC XY: 1AN XY: 222 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
296
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
222
show subpopulations
African (AFR)
AF:
AC:
0
AN:
10
American (AMR)
AF:
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
6
South Asian (SAS)
AF:
AC:
0
AN:
10
European-Finnish (FIN)
AF:
AC:
0
AN:
22
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
0
AN:
226
Other (OTH)
AF:
AC:
1
AN:
16
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0190 AC: 2893AN: 152392Hom.: 156 Cov.: 34 AF XY: 0.0209 AC XY: 1554AN XY: 74518 show subpopulations
GnomAD4 genome
AF:
AC:
2893
AN:
152392
Hom.:
Cov.:
34
AF XY:
AC XY:
1554
AN XY:
74518
show subpopulations
African (AFR)
AF:
AC:
163
AN:
41598
American (AMR)
AF:
AC:
1414
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
AC:
21
AN:
3472
East Asian (EAS)
AF:
AC:
729
AN:
5186
South Asian (SAS)
AF:
AC:
116
AN:
4834
European-Finnish (FIN)
AF:
AC:
164
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
236
AN:
68038
Other (OTH)
AF:
AC:
50
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
136
272
408
544
680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
286
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.